Trans American Aquaculture (GRPS) Receivables (2022)
Trans American Aquaculture (GRPS) reported Receivables of $92076.0 for Q4 2022.
Trans American Aquaculture (GRPS) Receivables (2022) Analysis & Trends
Trans American Aquaculture has reported Receivables for 1 years, with the latest figure at $92076.0 in Q4 2022.
- For the quarter ending Q4 2022, Receivables changed N/A year-over-year to $92076.0; the trailing twelve-month figure through Dec 2022 stood at $92076.0 (changed N/A YoY), and the FY2022 full-year result was $92076.0, changed N/A from the prior year.
- Receivables for Q4 2022 stood at $92076.0.
- The five-year high for Receivables was $92076.0 in Q4 2022, with the low at $92076.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 92,076.00 |